Out-patient lump-sum payment packages suggested to the Swiss Federal Council

03

Aug 2020

In June 2020, santésuisse (the leading organization of Swiss health insurers) and the Swiss Society of Surgeons (FCMH) have submitted a proposal to the Federal Council for the acceptance of 67 lump-sum payment packages for out-patient services. The lump-sum payment packages concern the following areas of care: hand surgery, radiology (MRI / CT), pediatric surgery, vascular medicine, eye surgery, and anesthesia.

The commonly acknowledged issue with the current reimbursement system is ineffective and unnecessary spending. Certain stakeholders of the out-patient reimbursement system proposed certain measures to increase the efficiency of spending. The following reasons set the basis for the rationale behind this action:

  • The same treatment will always cost the same, based on the national tariff structure with a uniform cost model
  • Eliminating the incentive of the care providers to bill unnecessary services (as TARMED / TARDOC are the fee-for-service catalogs)
  • The set price is only paid if the corresponding quality standards are also met, as the care providers and hospitals who join (optional) the collective agreement for out-patient lump-sum payment packages must participate in a recognized quality program

In July 2020, eight more lump-sum payment packages were suggested to the Federal Council. More suggestions are expected in the near future.

However, according to the director of curafutura (another health insurers’ association), “these lump-sums will cover only less than 20% of out-patient services.  Furthermore, this framework is optional. The lump-sums are not opposed to TARDOC, but represent a complement, as the two systems can coexist. In many areas of out-patient care, the lump sum will hardly be a viable alternative. In many cases, billing for individual services (fee-for-service) is more appropriate; the lump-sums are not always a better way to contain health care costs.” (reference)

Read the original announcement in German (change to French or Italian in the top-right corner) here.

Subscribe to our newsletter delivered every second week not to miss important reimbursement information.

The latest related news

18

Mar 2022

On February 22, 2022, a repository of innovative acts outside the nomenclature of biology and anatomopathology (RIHN) and a Supplementary list of IVD tests were published. Minor changes were introduced in the 2022 RIHN list.

Read more

14

Mar 2022

In February 2021, the Clinical Coding and Schedule Development (CCSD) working group, which develops and maintains procedural and diagnostics nomenclature for private payers in England, published Bulletins 0182 and 0079 with changes to be implemented no later than April 10, 2022. Three new procedure codes concerned robotic surgery in orthopaedic area, spinal procedures, and ophthalmology, and five new diagnostic codes were introduced.

Read more

08

Mar 2022

At the end of February 2022, the Dental and Pharmaceutical Benefits Agency (TLV) has launched a theme survey on products for monitoring and diagnostics of sepsis to identify products that may be relevant for health economic assessments at TLV. The suggestions for the products of interest, ongoing clinical studies, or innovation projects could be received until 23 March 2022.

Read more

07

Mar 2022

On February 08, 2022, the Reimbursement Commission of the Social Security Institution released an updated version of the Healthcare Implementation Communique. The main changes relate to the increase in reimbursement fees of services and medical devices by approximately 35-75%.

Read more

03

Mar 2022

In February 2022, two more health apps were introduced in the Directory of digital health applications (DiGAs) at the Federal Office for Drugs and Medical Devices (BfArM) and thus became reimbursable. These apps can be prescribed by physicians and psychotherapists and will be reimbursed by health insurers. In total, thirty health apps are now available at the DiGA Directory.

Read more